Formic Acid

Formic Acid

SCHEMBL17875586

C.N.O=CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL582126 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL83909 0.94
Formic Acid SCHEMBL2511100 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL13965548 0.94
Formic Acid SCHEMBL811681 0.94
Formic Acid SCHEMBL394887 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL2303 0.94
Formic Acid SCHEMBL18112628 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL1545869 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL1010784 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026105151-A1 IMPROVED IN-SITU SYNTHESIS OF AMINO METHYL PROPANOIC ACID OPTICELLAR INNOVATION PRIVATE LIMITED (IN) 2026-05-21 WO claimed
EP-4724065-A1 SYNERGISTIC COMPOSITION FOR MODULATING EXPRESSION OF CD38 Celagenex Research (India) Pvt. Ltd. (IN) 2026-04-15 EP claimed
WO-2024252409-A1 SYNERGISTIC COMPOSITION FOR MODULATING EXPRESSION OF CD38 Celagenex Research (India) Pvt. Ltd. (IN) 2024-12-12 WO claimed
EP-3297678-B1 AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LAURUS LABS LTD (IN) 2021-07-07 EP claimed
EP-3297678-A1 AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF Laurus Labs Private Limited (IN) 2018-03-28 EP claimed
WO-2016185450-A1 AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LAURUS LABS PRIVATE LIMITED (IN) 2016-11-24 WO claimed
EP-0578535-B1 New peptide derivates active in the process of cell adhesion, a method to prepare them end pharmaceutical compositions containing them ADIR (FR) 1996-08-21 EP claimed
WO-2026105151-A1 IMPROVED IN-SITU SYNTHESIS OF AMINO METHYL PROPANOIC ACID OPTICELLAR INNOVATION PRIVATE LIMITED (IN) 2026-05-21 WO disclosed
CN-106119113-B Organisms for the production of 1, 3-butanediol 基因组股份公司 2026-05-12 CN disclosed
EP-4724065-A1 SYNERGISTIC COMPOSITION FOR MODULATING EXPRESSION OF CD38 Celagenex Research (India) Pvt. Ltd. (IN) 2026-04-15 EP disclosed
US-20250376709-A1 PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL UNIV UTAH RES FOUND (US) 2025-12-11 US disclosed
US-20250326732-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-10-23 US disclosed
US-20250223306-A1 TEAD INHIBITORS AND METHODS OF USE SPOROS BIOVENTURES, INC., 2025-07-10 US disclosed
US-20070042497-A1 Diagnostic methods for determining susceptibility to convulsive conditions QUEENS UNIVERSITY AT KINGSTON (CA) 2007-02-22 US disclosed
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed
EP-1089964-A1 HYDRAZINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
WO-2000000465-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-01-06 WO disclosed
US-5565426-A ANTI-AGGREGATION, INHIBTION OF BLOOD CLOTTING ADIR ET COMPAGNIE (FR) 1996-10-15 US disclosed
US-4213996-A Phthalimide compounds and method for treating disorders of the heart INTERNATIONAL MINERALS & CHEMICAL CORPORATION (US) 1980-07-22 US disclosed